Tehran University of Medical Sciences

Science Communicator Platform

Share By
Design, Synthesis, in Vivo, and in Silico Studies of New [1,2,4] Triazolo[1,5-A]Pyrimidine-7(4H)-One Derivatives As Potent Anticonvulsant Agents Publisher



Fallah Kolamsary M ; Kabirifard H ; Dehpour A R ; Mahdavi M ; Mohammadi Khanaposhtani M
Authors

Source: Monatshefte fur Chemie Published:2026


Abstract

A new series of [1,2,4]triazolo[1,5-a]pyrimidine-7(4H)-one derivatives was designed, synthesized, and evaluated as potent anticonvulsant agents in pentylenetetrazole (PTZ) and maximal electroshock (MES) induced seizure models in mice. Latency times to the first symptom of seizure were measured, and the recorded data demonstrated that most of the newly synthesized compounds exhibited anticonvulsant activity in the PTZ test. Among them, the 4-bromobenzyl derivative showed the best anticonvulsant activity and was also the most potent compound in the MES assay. Considering that the new scaffold possesses the necessary pharmacophore units to act as a benzodiazepine receptor (BZDR) agonist, this most potent derivative was further evaluated in vivo and in silico for BZDR agonist activity. The in vivo evaluation using flumazenil, a BZDR antagonist, confirmed agonist action of the most potent compound at the BZDR. © Springer-Verlag GmbH Austria, part of Springer Nature 2026.